logo
#

Latest news with #SPRI

'Hail and Farewell' Ceremony Honors Incoming Fellows and Graduating Class of 2024–25 at Steadman Philippon Research Institute and The Steadman Clinic
'Hail and Farewell' Ceremony Honors Incoming Fellows and Graduating Class of 2024–25 at Steadman Philippon Research Institute and The Steadman Clinic

Associated Press

time04-08-2025

  • Health
  • Associated Press

'Hail and Farewell' Ceremony Honors Incoming Fellows and Graduating Class of 2024–25 at Steadman Philippon Research Institute and The Steadman Clinic

VAIL, Colo., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Each July, Steadman Philippon Research Institute (SPRI) and The Steadman Clinic pause to honor a time-honored tradition—celebrating the accomplishments of outgoing fellows while embracing the arrival of a new class of aspiring surgeons. This year's 'Hail and Farewell' ceremony, held on July 31 at Donovan Pavilion, marked a meaningful milestone in the journey of surgical fellows who have dedicated a year to intensive subspecialty training. The event brought together colleagues, mentors and staff to recognize the achievements of the departing 2024–25 fellows and welcome the incoming 2025–26 cohort. Ten new surgical fellows were welcomed to SPRI and The Steadman Clinic, embarking on a 12-month training program under the mentorship of internationally renowned surgeons, scientists and researchers. The fellowship programs include the ACGME-accredited Sports Medicine Fellowship, AOFAS-accredited Foot and Ankle Surgery Fellowship and the Spine Fellowship, welcoming its first fellow this year. As the new fellows began their journey, 10 graduating fellows concluded theirs—each stepping into advanced roles at some of the nation's leading clinics and hospitals. Their time at SPRI and The Steadman Clinic reflects not only technical excellence but a deep engagement with collaborative care and pioneering research. 'Over the past two decades, our fellows' program has produced some of the country's most distinguished orthopaedic surgeons,' said Marc J. Philippon, M.D., Managing Partner of The Steadman Clinic, Chairman of SPRI, and Co-Director of the Sports Medicine Fellowship and Hip Preservation & Reconstruction Fellowship. 'Their impact is evident not only across the field but right here at home—nine members of our current surgical team first joined us as fellows.' Fellows receive hands-on clinical training while also contributing to the future of orthopaedics through original research. Each fellow is responsible for authoring peer-reviewed projects and presenting their findings to the SPRI Research Faculty and Scientific Advisory Board prior to graduation. 'What sets our program apart is the depth of mentorship and the collaborative spirit that infuses both SPRI and The Steadman Clinic,' said Matthew T. Provencher, M.D., M.B.A., Co-Director of the Sports Medicine Fellowship. 'Fellows are integrated fully into patient care and research efforts. The relationships they build here—with staff, patients and each other—form a lasting foundation.' The program is guided by a group of esteemed faculty: Incoming fellows also benefit from close collaboration with Chief Scientific Officer Dr. Johnny Huard and his team at SPRI, whose research into biologic treatments and healthy aging is making a significant impact on orthopaedic clinical care. SPRI's departments also include Biomedical Engineering, which includes Robotics, Biomotion and Surgical Skills Laboratories and clinical outcomes research. Through the clinical fellowships, SPRI and The Steadman Clinic are committed to training the orthopaedic leaders of tomorrow in surgical excellence, patient care and the importance of research integration within clinical practice. The 10 physicians that form the incoming 2025-26 class of fellows are listed below, followed by the place of their medical residencies: Sports Medicine Monica Arney, M.D., University of Virginia Mikalyn DeFoor, M.D., CAPT, U.S.A.F., M.C., San Antonio Military Medical Center/Brooke Army Medical Center (Texas) Shane Korber, M.D., University of Southern California Devin Leland, M.D., Mayo Clinic (Minn.) Charles Lin, M.S., M.D., New York University Langone Health Lucy Meyer, M.D., Duke University (N.C.) Brendon Mitchell, M.A., M.D., University of California San Diego Colby Wollenman, M.D, Vanderbilt University (Tenn.) Foot & Ankle Elise Grzeskiewicz, M.D., Vanderbilt University (Tenn.) Spine Patrick Young, M.D., University of South Alabama The outgoing fellows from the Class of 2024-25, followed by their new professional positions: Sports Medicine Neil Blanchard, M.D., Penn State Health (Pa.) Joseph Featherall, M.D., University of Utah Samuel Huntley, M.D., M.P.H., Orthopedic Centers of Colorado Jason Long, M.D., M.B.A., Nebraska Orthopedic Center Colin Murphy, M.D., Southeast Orthopedic Specialists (Fla). Benjamin Rothrauff, M.D., Ph.D., Atrium Health (N.C.) Jordan Teel, M.D, United Regional Health Group (Texas) Tyler Uppstrom, M.D., Boston University Chobanian & Avedisian School of Medicine (Mass.) Foot & Ankle Chase Matthew Romere, M.D., Texas Orthopedics Hip Mazen Mohamed Ibrahim, MBBCh, M.D., Ph.D., Children's Bone and Spine, (Nev.) For further information, contact Lynda Sampson, ( [email protected], 970/479-1563) Lynda Sampson Steadman Philippon Research Institute 970-479-1563 [email protected]

MEI Micro partners with Steadman Philippon Research Institute in new technology development
MEI Micro partners with Steadman Philippon Research Institute in new technology development

Cision Canada

time26-06-2025

  • Business
  • Cision Canada

MEI Micro partners with Steadman Philippon Research Institute in new technology development

SANTA BARBARA, Calif., June 26, 2025 /CNW/ -- MEI Micro, Inc. is partnering with Steadman Philippon Research Institute (SPRI) to develop new technology and product platforms that will help establish new standards in accuracy and precision for a number of applications related to MedTech, healthcare, sports medicine and athletic performance. The partnership will bring together MEI's expertise in next-generation MEMs inertial sensor technology and the deep subject matter expertise of SPRI, one of the world's leading Institutes of orthopaedics and sports medicine research. The focus will include the development of smart surgical tools, medical-grade wearables and motion capture systems for the assessment and continuous monitoring of patients, athletes and military personnel. These systems will feature MEI's proprietary 3DS MEMs platform technology which is 80x–100x more accurate than existing consumer- and industrial-grade MEMs inertial sensors currently in use in life science applications including consumer wearables like smart watches and rings. "There is tremendous potential in this innovative partnership between MEI Micro and SPRI," shared Marc J. Philippon, MD, Managing Partner of The Steadman Clinic and Chairman of SPRI. "Harnessing MEI's technology will enable us to develop new products for surgical advancement while enhancing the patient's recovery experience through next-generation technology." MEI Micro recently began shipping first commercial product samples of its industry first navigation-grade, multi-axis chip scale 3 degrees of freedom (DoF) MEMs accelerometer platform, which received the Most Innovative Product Award for MEMs at the 2024 Sensors Converge conference. At this year's event, CEO Louis Ross will present " Next Generation MEMS Inertial for Life Science Applications" and will review its plans to work closely with SPRI, which has a long history of developing leading-edge approaches to orthopaedic surgery and conducting research to support the care of some of the world's top professional athletes and the U.S. Olympic and Paralympic teams. "We look to democratize the use of high-accuracy inertial data", said Ross, which includes delivering the highest accuracy, lowest cost, size, weight and power (CSWaP) sensors to be put on the market. "The need for much higher accuracy has been accelerated due to the broad-spread application of artificial intelligence and machine learning, especially at the EDGE, which includes the Internet of Medical Things (IoMT)." EDGE computing, also referred to as "TinyML", requires higher accuracy data in order to develop more efficient sensor fusion software and advanced algorithms that can become a catalyst for preventative, predictive and personalized healthcare and related assessments and medical treatments. MEMs inertial sensors also provide the ability to continuously track and monitor users, providing a key enabler for telemedicine/telehealth which will lead to lower costs for clinical trials and healthcare in general. "SPRI's partnership with MEI Micro will result in the development of a portfolio of healthcare technological advancements," said Dan Drawbaugh, CEO of SPRI. "As SPRI expands its artificial intelligence and machine learning capabilities, there is a natural synergy with MEI Micro's technologies for precision-based solutions. We look forward to working with MEI Micro to change the shape of personalized healthcare on a global scale." The organizations plan to develop new technology products, including targeted orthopaedic and sports medicine applications for individual joints, with the ultimate goal of advancing patient treatment, care and recovery. MEI Micro, Inc. is a technology start up commercializing the world's first tactical to navigation grade capable, multi-axis, chip scale MEMs inertial sensor systems. The company's 3DS proprietary MEMs platform technology includes MEMs manufacturing process, advanced semiconductor packaging, MEMs device design and applications related intellectual property. The company works closely with partners to develop custom, application specific solutions enabled by its 3DS MEMs inertial measurement units (IMUs) and inertial navigation systems (INSs). Steadman Philippon Research Institute (SPRI) is dedicated to keeping people of all ages physically active through orthopaedic research and education. With an enduring focus on applied clinical translation, SPRI is dedicated to discovering new therapies, treatments and cures that can be brought to patients in a clinical setting. SPRI utilizes the latest regenerative medicine techniques—basic science studies at the cellular level—to investigate the causes and effects of degenerative arthritis, techniques of musculoskeletal regeneration and healing processes. SPRI also uses state-of-the-art Biomotion and Robotics technologies, magnetic resonance imaging and over 35 years of patient outcomes data in its bench-to-bedside approach to research. The 501(c)(3) charitable organization is one of the most published organizations in sports medicine research and education.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store